Zigakibart

• UNSPSC Description:

  Zigakibart (BION-1301) is an IgG4-kappa, anti-TNFSF13 (tumor necrosis factor (TNF) superfamily member 13, APRIL, CD256) humanized monoclonal antibody. Zigakibart shows anti-inflammatory activity[1].

• Target Antigen:

  TNF Receptor

• Type:

  Inhibitory Antibodies

• Related Pathways:

  Apoptosis

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Inflammation/Immunology; Cancer

• Assay Protocol:

  https://www.medchemexpress.com/zigakibart.html

• Purity:

  98.37

• Solubility:

  H2O

• Smiles:

  [Zigakibart]

• References & Citations:

  [1]International Nonproprietary Names for Pharmaceutical Substances (INN). WHO Drug Information, Vol. 36, No. 2, 2022.

• Shipping Conditions:

  Dry Ice

• Storage Conditions:

  -80°C

• Clinical Information:

  Phase 3

• CAS Number:

  2642175-46-8